BNP Paribas Financial Markets
ZYBT

BNP Paribas Financial Markets’s Zhengye Biotechnology Holding ZYBT Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZYBT Stock Details ZYBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-262
Closed -$1.56K – 5827
2025
Q2 		$1.56K Buy
+262
New +$2.08K ﹤0.01% 5101

Other funds holding ZYBT

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

BNP Paribas Financial Markets's ZYBT Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Zhengye Biotechnology Holding (ZYBT) in Q3 2025, closing a stake of 262 shares — an estimated $1.56K sold.

BNP Paribas Financial Markets first reported a position in ZYBT in Q2 2025 and held it in 1 quarter. The position peaked at $1.56K in Q2 2025. 10 funds tracked by Wall St. Rank hold ZYBT as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Zhengye Biotechnology Holding position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 262 Zhengye Biotechnology Holding shares in Q3 2025, an estimated $1.56K.
  • BNP Paribas Financial Markets first reported a position in Zhengye Biotechnology Holding in Q2 2025 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Zhengye Biotechnology Holding position peaked at $1.56K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Zhengye Biotechnology Holding as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.